Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The number of days to an undetectable viral load dropped by nearly two weeks, but there’s more work to do.
An HIV prevention roundup
Globally, a child contracts HIV every 100 seconds. A new, affordable treatment is available, but the COVID-19 pandemic hinders access.
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
Researchers used mathematical modeling to analyze the projected benefits of more frequent HIV testing in this population.
A recent NIH study found that adults have a much higher viral suppression rate than youth.
The CDC has issued a report detailing considerations for clinicians prescribing PrEP for this population.
The association between viral load and cardiovascular disease risk has been under-investigated among young people with HIV.
This special issue is dedicated to young people, who represent a majority of new HIV cases.
Dee Mphafi is an HIV advocate from Lesotho, Africa.
Teenagers are attempting suicide with opioids at increasing rates.
Researchers have called for improved communication about sexual orientation and HIV testing between pediatricians and adolescents.
The vaccine is safe and effective against cancer-causing strains of HPV, and yet anti-vaccination misinformation campaigns have taken hold.
A long-term study sought to determine which factors help predict low adherence among young people with the virus.
A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.